Suchergebnisse - "Haslwanter, Denise"

PubPharm (35)

1

Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody

enthalten in: Science translational medicine | 2023

von Mittler, E. | Serris, A. | Esterman, E. | +29

2

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine : a randomised, placebo-controlled, first-in-human trial

enthalten in: Lancet (London, England) | 2023

von Tschismarov, R. | Van Damme, P. | Germain, C. | +13

CommentIn: Lancet. 2023 Apr 15;401(10384):1242-1243. - PMID 36934735

3

A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants

enthalten in: bioRxiv.org | 2022

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27

4

Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC

enthalten in: bioRxiv.org | 2022

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

5

Development, clinical translation, and utility of a COVID-19 antibody test with qualitative and quantitative readouts

enthalten in: bioRxiv.org | 2022

von Bortz, R. | Florez, C. | Laudermilch, E. | +38

6

Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis

enthalten in: bioRxiv.org | 2022

von Herrera, N. | Morano, N. | Celikgil, A. | +31

7

A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition

enthalten in: bioRxiv.org | 2022

von Dieterle, M. | Haslwanter, D. | Bortz, R. | +20

8

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference

enthalten in: Cold Spring Harbor molecular case studies | 2022

von Fels, J. | Khan, S. | Forster, R. | +21

UpdateOf: medRxiv. 2022 Mar 17;:. - PMID 33594384

9

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

enthalten in: PLoS pathogens | 2022

von Malonis, R. | Georgiev, G. | Haslwanter, D. | +9

10

Genotype-specific Features Reduce the Susceptibility of South American Yellow Fever Virus Strains to Vaccine-Induced Antibodies

enthalten in: bioRxiv.org | 2022

von Haslwanter, D. | Lasso, G. | Wec, A. | +17